This website may not work correctly in Internet Explorer. We recommend switching to a more secure modern web browser such as Microsoft Edge which is already installed on your computer.

View this website in Edge.

Osteogenesis Imperfecta Explained

Osteogenesis Imperfecta (OI) means “bones formed imperfectly”. These are genetic conditions that someone is born with, and will throughout their life. They primarily affect the bones, causing them to be fragile. We currently recognize over 20 distinct genetic causes. There are a similar number of genetically determined related forms of Familial Osteoporosis.

Osteogenesis Imperfecta (OI) is the Latin term for a large group of rare disorders with imperfect development (genesis) of bones (Osteo-). The conditions are inborn and the tendency to bone fragility persists throughout life.  As well as an intrinsic tendency to fracture bones more easily (brittle bones) people with OI may develop osteoporosis, which contributes further to bone bowing, and sometimes deformities of long bones and spine. It is estimated that roughly 7 people per 100 000 are born with OI.

OI may also result in blue tinted sclerae (the white of the eyes), short stature, hearing loss, brittle teeth with opalescent discolouration (Dentinogenesis Imperfecta), muscle weakness, joint hypermobility and restricted breathing.

There are currently 5 clinical groups known as Types of OI (each with many sub-types) that vary in the level of fragility and other properties.  The International Committee for naming OI disorders recommended in 2023 that health professionals and people with OI use a dual (Dyadic) named diagnosis.  Over 20 genetic causes of OI have been identified and there are over 20 other bone fragility disorders which can be hard to distinguish from OI.  People with OI are all unique!  No two people display exactly the same characteristics of OI, even within the established Types.

The commonest form of OI in many populations is known as Type 1, which is characterized by distinctly blue sclerae (whites of the eyes) and autosomal dominant inheritance.  It is often associated with adult hearing loss, but rarely with deformity of long bones or spine.  Another common form with lifelong bone fragility but normal sclerae is known as Common Variable OI Type 4 and can often go undiagnosed until later in life.  Type 3 OI includes many genetic variants with early fractures and a tendency to bowing of long bone and short stature. People with Type 5 OI have a dominantly inherited, very variable form of OI which results in bone forming between the bones of the forearm causing elbow dislocation. 

Children born with more severe Types of OI can often sustain fractures in the womb or during childbirth. The most severe cases of OI can result in infant death, often due to respiratory failure during or shortly after birth and are grouped as OI Type 2.

There are numerous subtypes and these need to be distinguished from special syndromes with Osteoporosis (e.g. Bruck syndromes of Osteoporosis with Joint Contractures or Cole-Carpenter syndromes with premature closure of cranial sutures (craniosynostosis).

 

 

Introduction to Bone Fragility syndromes
A new Dyadic Naming System for OI and Bone Fragility syndromes
Bone fragility is shared with many other rare disorders
Digenic Inheritance of OI and Bone Fragility in some families
Recognising Sex-Linked inheritance and its consequence for families
Multidisciplinary Care Clinics have revolutionized care of people with OI.

Read moreabout Osteogenesis Imperfecta And Bone Fragility in 2024

OI is usually diagnosed as a result of family history and/or clinical observation. In most cases OI will be detected early on in a child’s life as a result of the child having a number of fractures. In addition to this some key clinical observations may be present such as:
Blue Sclerae (whites of the eyes) – this is a characteristic feature of OI Type 1 but is not present in all forms of OI. It may be a normal feature in some babies in the first 2 years of life

Read moreabout OI Diagnosis

Osteogenesis imperfecta (OI) is the result of a mutation in one of the two genes that carry instructions for making type 1 collagen (the major protein in bone and skin). Collagen is the major protein of the body’s connective tissue and can be likened to the framework around which a building is constructed. In OI, a person has either less collagen than normal, or a poorer quality of collagen than normal, leading to weak bones that fracture easily.

Read moreabout Causes

OI is treated primarily by managing fractures and promoting as much mobility and independence as possible. Prolonged immobility can further weaken bones and lead to muscle loss, weakness, and more fractures. Many orthopedists prefer to treat fractures with short-term immobilization in lightweight casts, splints, or braces to allow some movement as soon as possible after the fracture.

Read moreabout Research and Treatments

What is a fracture?

A fracture is a break in the bone or cartilage. It usually is a result of trauma.

It can, however, be a result of disease of the bone that leads to weakening, such as osteoporosis, or abnormal formation of the bone from congenital diseases at birth, such as osteogenesis imperfecta.

Read moreabout Types of Fractures

Welcome to our glossary of medical terms! This guide is designed to help you easily understand common phrases, terminology, and lingo used throughout our website. We know that medical language can sometimes be confusing, so we've created this resource to provide clear, simple definitions to help you navigate the content with confidence. We hope you find this glossary helpful.

Read moreabout Glossary of Terms

News and events

View all